Gareth Sheridan’s Post

View profile for Gareth Sheridan, graphic

CEO Nutriband Inc. (NASDAQ: NTRB)

Great to speak with Richard Curran today on RTE's The Business about Nutriband Inc. (Nasdaq: NTRB) and how we are developing our #AVERSA technology to tackle the complicated opioid crisis. Nutriband listed on the Nasdaq in October 2021 and since then the entire team has been laser focused on taking our #AVERSA technology through clinical development as we aggressively target Q1 of 2025 to file for approval. AVERSA™ Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world and is estimated to have the potential to reach peak annual US sales of $80 million to $200 million, according to a market analysis report from Health Advances. https://lnkd.in/ep2Niv7V #irishbusiness

Gareth Sheridan

Gareth Sheridan

rte.ie

A truly brilliant interview and a story to continue to great successes. Well done Gareth.

To view or add a comment, sign in

Explore topics